Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426477 · ClinicalTrials.gov registry record
Veritas in Non-Bridging Ventral Hernia Repair
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- 20
- Enrollment target
NCT01426477: Clinical Trial study, sponsored by Baxter Healthcare Corporation.
NCT01426477 is a clinical trial that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01426477 was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The main study objective is to determine the frequency of hernia recurrence following use of Veritas Collagen Matrix.
Primary Outcome
Recurrence will be evaluated through physical exam and/or CT scans at all study visits (30 days, 6 months, 1 year, and 2 years), or when patients present with symptoms, with primary endpoint at 2 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-08 |
Why NCT01426477 stopped before completion
NCT01426477 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01426477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01426477 about?
NCT01426477 is a clinical study titled "Veritas in Non-Bridging Ventral Hernia Repair". The main study objective is to determine the frequency of hernia recurrence following use of Veritas Collagen Matrix.
What is the current status of trial NCT01426477?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2011-08. Estimated completion is 2017-08.
Who is sponsoring clinical trial NCT01426477?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia